Literature DB >> 15289302

Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers.

Tari A King1, Mary L Gemignani, Weiwei Li, Dilip D Giri, Kathy S Panageas, Faina Bogomolniy, Crispinita Arroyo, Narciso Olvera, Mark E Robson, Kenneth Offit, Patrick I Borgen, Jeff Boyd.   

Abstract

The study of pathologically normal breast epithelium of BRCA mutation carriers may yield insights into the early natural history of breast tumorigenesis. Hormone receptor expression was assessed in 24 cases of invasive breast cancer associated with a mutation in BRCA1 (n = 15) or BRCA2 (n = 9) and in 39 sporadic cases matched for patient age and tumor hormone receptor status. Expression of progesterone receptor was significantly (P = 0.0003) more common in normal breast epithelium adjacent to invasive breast carcinoma in BRCA1-linked cases compared with sporadic cases. The wild-type BRCA allele was retained in normal epithelium of all cases tested. We conclude that deregulation of progesterone receptor expression, as a result of BRCA1 haploinsufficiency, may represent an early event in BRCA1-linked breast tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15289302     DOI: 10.1158/0008-5472.CAN-04-1283

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study.

Authors:  Yakir Segev; Barry Rosen; Jan Lubinski; Jacek Gronwald; Henry T Lynch; Pal Moller; Charmaine Kim-Sing; Parviz Ghadirian; Beth Karlan; Charis Eng; Dawna Gilchrist; Susan L Neuhausen; Andrea Eisen; Eitan Friedman; David Euhus; Sun Ping; Steven A Narod
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

2.  The chemopreventive effect of mifepristone on mammary tumorigenesis is associated with an anti-invasive and anti-inflammatory gene signature.

Authors:  Hongyan Yuan; Geeta Upadhyay; Jin Lu; Levy Kopelovich; Robert I Glazer
Journal:  Cancer Prev Res (Phila)       Date:  2012-03-16

3.  Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells.

Authors:  Hiroyuki Konishi; Morassa Mohseni; Akina Tamaki; Joseph P Garay; Sarah Croessmann; Sivasundaram Karnan; Akinobu Ota; Hong Yuen Wong; Yuko Konishi; Bedri Karakas; Khola Tahir; Abde M Abukhdeir; John P Gustin; Justin Cidado; Grace M Wang; David Cosgrove; Rory Cochran; Danijela Jelovac; Michaela J Higgins; Sabrina Arena; Lauren Hawkins; Josh Lauring; Amy L Gross; Christopher M Heaphy; Yositaka Hosokawa; Edward Gabrielson; Alan K Meeker; Kala Visvanathan; Pedram Argani; Kurtis E Bachman; Ben Ho Park
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

4.  BRCA1 Attenuates Progesterone Effects on Proliferation and NFκB Activation in Normal Human Mammary Epithelial Cells.

Authors:  H N Hilton; L J Patterson McDonald; N Santucci; F R van der Bent; A Silvestri; J D Graham; C L Clarke
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-05-18       Impact factor: 2.673

5.  RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.

Authors:  Emma Nolan; François Vaillant; Daniel Branstetter; Bhupinder Pal; Göknur Giner; Lachlan Whitehead; Sheau W Lok; Gregory B Mann; Kathy Rohrbach; Li-Ya Huang; Rosalia Soriano; Gordon K Smyth; William C Dougall; Jane E Visvader; Geoffrey J Lindeman
Journal:  Nat Med       Date:  2016-06-20       Impact factor: 53.440

Review 6.  Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers.

Authors:  Marieke A Vollebergh; Jos Jonkers; Sabine C Linn
Journal:  Cell Mol Life Sci       Date:  2011-09-16       Impact factor: 9.261

7.  The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.

Authors:  Yongxian Ma; Pragati Katiyar; Laundette P Jones; Saijun Fan; Yiyu Zhang; Priscilla A Furth; Eliot M Rosen
Journal:  Mol Endocrinol       Date:  2005-08-18

8.  Association of hormone receptor status with grading, age of onset, and tumor size in BRCA1-associated breast cancer.

Authors:  M Graeser; K Bosse; M Brosig; C Engel; R K Schmutzler
Journal:  Virchows Arch       Date:  2009-04-21       Impact factor: 4.064

9.  Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity.

Authors:  Pragati Katiyar; Yongxian Ma; Anna Riegel; Saijun Fan; Eliot M Rosen
Journal:  Mol Endocrinol       Date:  2009-04-23

Review 10.  BRCA1, hormone, and tissue-specific tumor suppression.

Authors:  Yanfen Hu
Journal:  Int J Biol Sci       Date:  2008-12-13       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.